Literature DB >> 15720456

Characterization of right atrial substrate in patients with supraventricular tachyarrhythmias.

Yenn-Jiang Lin1, Ching-Tai Tai, Jin-Long Huang, Kun-Tai Lee, Pi-Chang Lee, Ming-Hsiung Hsieh, Shih-Huang Lee, Satoshi Higa, Yoga Yuniadi, Tu-Ying Liu, Shih-Ann Chen.   

Abstract

UNLABELLED: Right atrial substrate of supraventricular tachyarrhythmias.
BACKGROUND: Voltage mapping has been used to detect diseased myocardium. However, accurate determination of the local atrial voltage at the same site, and simultaneous recordings from multiple mapping sites were limited. The purpose of this study was to investigate the right atrial (RA) substrate properties in patients with supraventricular tachyarrhythmias (SVT). METHODS AND
RESULTS: Forty patients (aged 55+/-20 years) undergoing noncontact mapping and ablation of SVT constituted the study population. There were eight patients with atrioventricular node reentrant tachycardia (AVNRT), eight patients with focal atrial tachycardia (AT), 14 patients with atrial flutter (AFL), and 10 patients with atrial fibrillation (AF). The mean peak negative voltage (PNV) was analyzed in virtual unipolar electrograms, which were obtained from 256 equally distributed RA endocardial sites during sinus rhythm (SR), atrial pacing, and tachycardia. The mean PNV of global RA during SR (-1.34+/-0.22 vs. -0.90+/-0.40 vs. -1.00+/-0.36 vs. -0.85+/-0.35 mV, P=0.04), atrial pacing at cycle lengths of 500 ms (-1.30+/-0.29 vs. -0.70+/-0.35 vs. -0.76+/-0.25 vs. -0.64+/-0.26 mV, P=0.02), and 300 ms (-1.54+/-0.47 vs. -0.94+/-0.21 vs. -0.75+/-0.27 vs. -0.57+/-0.22 mV, P<0.01) were significantly greater in patients with AVNRT compared to AT, AFL, and AF. Furthermore, the mean PNV decreased during atrial pacing with shorter pacing cycle length was demonstrated only in patients with AFL and AF.
CONCLUSION: Negative unipolar voltage analysis of global RA showed different RA substrate characteristics during various SVT. The substrate property of activation and cycle length-dependent voltage reduction may be related to the development of AFL and AF.

Entities:  

Mesh:

Year:  2005        PMID: 15720456     DOI: 10.1046/j.1540-8167.2005.40513.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

1.  The roles of anatomy, image, and electrogram voltage in ablation of cavotricuspid isthmus.

Authors:  Shih-Ann Chen; Satoshi Higa
Journal:  J Interv Card Electrophysiol       Date:  2005-01       Impact factor: 1.900

Review 2.  Impact of Smoking on the Atrial Substrate Characteristics in Patients with Atrial Fibrillation.

Authors:  Ta-Chuan Tuan; Shih-Lin Chang; Shih-Ann Chen
Journal:  J Atr Fibrillation       Date:  2008-09-16

Review 3.  Differences of BiAtrial Substrate Properties in Patients with Different Types of AF.

Authors:  Kazuyoshi Suenari; Hidekazu Hirao; Mitsunori Okamoto; Yasuki Kihara; Shih-Ann Chen
Journal:  J Atr Fibrillation       Date:  2012-12-16

Review 4.  Clinical Relevance of Sinus Rhythm Mapping to Quantify Electropathology Related to Atrial Fibrillation.

Authors:  Mathijs S van Schie; Natasja Ms de Groot
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

5.  Intrinsic Cardiac Autonomic Ganglionated Plexi within Epicardial Fats Modulate the Atrial Substrate Remodeling: Experiences with Atrial Fibrillation Patients Receiving Catheter Ablation.

Authors:  Rahul Singhal; Li-Wei Lo; Yenn-Jiang Lin Lin; Shih-Lin Chang; Yu-Feng Hu; Tze-Fan Chao; Fa-Po Chung; Cheun-Wang Chiou; Hsuan-Ming Tsao; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2016-03       Impact factor: 2.672

6.  The Different Substrate Characteristics of Arrhythmogenic Triggers in Idiopathic Right Ventricular Outflow Tract Tachycardia and Arrhythmogenic Right Ventricular Dysplasia: New Insight from Noncontact Mapping.

Authors:  Van Buu Dan Do; Wen-Chin Tsai; Yenn-Jiang Lin; Satoshi Higa; Nobumori Yagi; Shih-Lin Chang; Li-Wei Lo; Fa-Po Chung; Jo-Nan Liao; Yen-Chang Huang; Chao-Shun Chan; Hung-Kai Huang; Yu-Feng Hu; Hsuan-Ming Tsao; Shih-Ann Chen
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.